Venus Remedies' Tobracef gets South African patent

Venus Remedies Limited, a Haryana-based leading research based company, has announced that the company has received patent for Tobracef from the Companies and Intellectual Property Registration Office (CIPRO), South Africa.

Tobracef is indicated for the treatment of complicated mixed bacterial infection of acute pulmonary exacerbations/custic fibrosis/chronic obstructive pulmonary disease. The product is a novel fixed dose combination of cephalosporin and aminoglycoside.


Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying